+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interleukin"

Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • January 2020
  • 130 Pages
  • Global
From
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • October 2019
  • 128 Pages
  • Global
From
Gastrointestinal Disorders: Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac Disease - Product Thumbnail Image

Gastrointestinal Disorders: Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac Disease

  • Report
  • March 2019
  • 165 Pages
  • Global
From
Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Atopic Dermatitis: Global Drug Forecast and Market Analysis to 2027

  • Report
  • November 2018
  • 108 Pages
  • Global
From
Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026 - Product Thumbnail Image

Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026

  • Report
  • June 2018
  • 52 Pages
  • Global
From
Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline - Product Thumbnail Image

Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline

  • Report
  • June 2019
  • 53 Pages
  • Global
From
Market Spotlight: Celiac Disease - Product Thumbnail Image

Market Spotlight: Celiac Disease

  • Report
  • March 2021
  • 25 Pages
  • Global
Market Spotlight: Axial Spondyloarthritis (axSpA) - Product Thumbnail Image

Market Spotlight: Axial Spondyloarthritis (axSpA)

  • Report
  • March 2021
  • 52 Pages
  • Global
Market Spotlight: Gout - Product Thumbnail Image

Market Spotlight: Gout

  • Report
  • January 2021
  • 38 Pages
  • Global
Interleukin 11 (Adipogenesis Inhibitory Factor or Oprelvekin or IL11) - Drugs in Development, 2021 - Product Thumbnail Image

Interleukin 11 (Adipogenesis Inhibitory Factor or Oprelvekin or IL11) - Drugs in Development, 2021

  • Report
  • April 2021
  • 30 Pages
  • Global
From
Interleukin 1 - Pipeline Review, H2 2020 - Product Thumbnail Image

Interleukin 1 - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 156 Pages
  • Global
From
Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H1 2020 - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 68 Pages
  • Global
From
Interleukin 1 Receptor Type 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Interleukin 1 Receptor Type 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 54 Pages
  • Global
From
C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 69 Pages
  • Global
From
Axial Spondyloarthritis: Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Forecast in Asia-Pacific Markets to 2028

  • Report
  • February 2020
  • 150 Pages
  • Asia Pacific
From
Frontier Pharma: Type 1 Diabetes Insulin Gene Therapy and Immuno-modulators Dominate First-in-Class Pipeline with Novel Target Classes Demonstrating Potential Beta-Cell Regeneration - Product Thumbnail Image

Frontier Pharma: Type 1 Diabetes Insulin Gene Therapy and Immuno-modulators Dominate First-in-Class Pipeline with Novel Target Classes Demonstrating Potential Beta-Cell Regeneration

  • Report
  • October 2019
  • 57 Pages
  • Global
From
Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease - Product Thumbnail Image

Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease

  • Report
  • September 2019
  • 55 Pages
  • Global
From
Crohn's Disease: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Crohn's Disease: Dynamic Market Forecast to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Immunology Drugs Market Report Suite for the United States - 2018-2024 - Product Thumbnail Image

Immunology Drugs Market Report Suite for the United States - 2018-2024

  • Report
  • April 2018
  • United States
From
Stelara - Product Thumbnail Image

Stelara

  • Report
  • August 2018
  • 57 Pages
  • Global
From
Loading Indicator

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases. In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more